Please Wait
Applying Filters...
menu
    • menu
    FDA approvals drop 24% in H1 2025; GSK’s UTI med, Vertex’s non-opioid painkiller lead pack of first-in-class meds

    Data Compilation
    #PharmaFlow

    Pipeline Prospector August 2025: Novo’s Wegovy approved for MASH, Tonix Pharma’s fibromyalgia drug okayed

    Stock Recap
    #PipelineProspector

    Menu

    Cilastatin Sodium

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,095Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Name of the Firm Written Confirmation No. Product Name Issue Date Valid Till Address of the Firm
    06/09/2025 Sun Pharmaceutical Industries Limited
    India
    		 M/sSun Pharmaceutical Industries Ltd WC-0216 Imipenem USP and Cilastatin Sodium USP (SterileBlend) USP 10-07-2025 04-07-2028 Industrial Area-03, A. B. Road, Dewas — 455 001, Madhya Pradesh, India.
    06/09/2025 Sun Pharmaceutical Industries Limited
    India
    		 M/sSun Pharmaceutical Industries Ltd WC-0216 Imipenem Ph. Eur. and Cilastatin Sodium Ph. Eur.Sterile Blend Ph. Eur 10-07-2025 04-07-2028 Industrial Area-03, A. B. Road, Dewas — 455 001, Madhya Pradesh, India.